BRITTANY HO: Open Payments
NPI 1629695044 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,561 in 112 payments from 23 companies in 2025. Trend: 2023 $1,629 · 2024 $1,986 · 2025 $2,561
Food & beverage: $2,477Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $683 |
| Janssen Biotech, Inc. | 9 | $234 |
| Ardelyx, Inc. | 8 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $205 |
| Ipsen Biopharmaceuticals, Inc | 10 | $194 |
| Madrigal Pharmaceuticals | 6 | $151 |
| Enterra Medical, Inc. | 2 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| GENZYME CORPORATION | 3 | $88 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
Products named: SKYRIZI, RINVOQ, IBSRELA, ENTYVIO, IQIRVO, REZDIFFRA, TREMFYA, DUPIXENT.
Industry payments across TX — which companies pay providers there.
